[Treatment of epidemic conjunctivitis].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003231:Conjunctivitis / Q000188:drug therapy*; D004196:Disease Outbreaks / Q000453:epidemiology*; D004338:Drug Combinations; D005601:Framycetin / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone; D009824:Ointments; D010118:Oxytetracycline / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D015006:Yemen
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D009824:Ointments; D013424:Sulfanilamides; D005601:Framycetin; D002701:Chloramphenicol; D013752:Tetracycline; D006854:Hydrocortisone; D010118:Oxytetracycline
lecheniilechen-i